Endothelial cell injury in cardiovascular surgery

Annals of Thoracic Surgery

Volumn 62, Issue 3, 1996, Pages 915-922

  Verrier, Edward D ^a,b   Boyle Jr , Edward M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERY INTIMA PROLIFERATION; BLOOD CLOTTING; BLOOD VESSEL INJURY; BLOOD VESSEL TONE; CARDIOVASCULAR SURGERY; CELL ADHESION; HUMAN; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; VASCULAR ENDOTHELIUM;

EID: 0030248216     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00528-0     Document Type: Review

References (69)

1. 1. Verrier ED. The vascular endothelium: friend or foe? Ann Thorac Surg 1993;55:818-9.
2. 2. Luscher TF, Tanner FC, Tschundi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med 1993;44:395-418.
3. 3. Lefer A, Lefer D. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993;33:71-90.
4. 4. Crossman DC, Tuddenham EG. Procoagulant functions of the endothelium. In: Warren JB, ed. The endothelium: an introduction to current research. New York: Wiley-Liss, 1990:119-28.
5. 5. Schwartz SM, deBlois D, OBrien ER. The intima: soil for atherosclerosis and restenosis. Circ Res 1995;77:445-65.
6. 6. Harlan J. Leukocyte-endothelial interactions. Blood 1985;65: 513-25.
7. 7. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995;57:791-804.
8. 8. Pober JS, Cotran RS. Cytokines and endothelial cell biology. Physiol Rev 1990;70:427-51.
9. 9. Davies MG, Hagen PO. The vascular endothelium: a new horizon. Ann Surg 1993;218:593-609.
10. 10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-9.
11. 11. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 1990;323:27-36.
12. 12. Luscher TF. Vascular biology of coronary artery bypass grafts. Coronary Artery Dis 1992;3:157-65.
13. 13. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest 1991;88: 1054-7.
14. 14. Pearson PJ, Evora RB, Schaff HV. Bioassay of EDRF from internal mammary arteries: implications for early and late bypass graft patency. Ann Thorac Surg 1992;54:1078-84.
15. 15. Chua YL, Pearson PJ, Evora PR, Schaff HV. Detection of intraluminal release of endothlium-derived relaxing factor from human saphenous veins. Circulation 1993;88:128-32.
16. 16. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993;33:71-90.
17. 17. Edgington T, Ruf W, Rehemtulla A, Mackman N. The molecular biology of initiation of coagulation by tissue factor. Curr Stud Hematol Blood Transfus 1991;58:15-21.
18. 18. Chandler W. The effects of cardioipulmonary bypass on fibrin formation and lysis: is a normal fibrinolytic response essential? J Cardiovasc Pharmacol 1996;27:S63-8.
19. 19. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990;76:1680-97.
20. 20. Bevilacqua MP, Pober JS, Wheeler ME, et al. Interleukin-1 activation of vascular endothelium. Effects on procoagulant activity and leukocyte adhesion. Am J Pathol 1985;121:394-403.
21. 21. Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986;83:4533-7.
22. 22. Johnson M, Haddix T, Pohlman T, Verrier ED. Hypothermia reversibly inhibits endothelial cell expression of E-selectin and tissue factor. J Cardiac Surg 1995;10:428-35.
23. 23. Schorer AE, Kaplan ME, Rao GH, Moldow CF. Interleukin 1 stimulates endothelial cell tissue factor production and expression by a prostaglandin-independent mechanism. Thromb Haemost 1986;56:256-9.
24. 24. Crossman DC, Carr DP, Tuddenham EG, et al. The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester. J Biol Chem 1990; 265:9782-7.
25. 25. Moore KL, Andreoli SP, Esmon NL, et al. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987;79:124-30.
26. 26. Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740-5.
27. 27. Bevilacqua MP, Schleef RR, Gimbrone MA Jr, Loskutoff DJ. Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1. J Clin Invest 1986;78: 587-91.
28. 28. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost 1993;70:259-62.
29. 29. Ray MJ, Hawson GA, Just SJ, et al. Relationship of platelet aggregation to bleeding after cardiopulmonary bypass. Ann Thorac Surg 1994;57:981-6.
30. 30. Spiess BD. The contribution of fibrinolysis to postbypass bleeding. J Cardiothorac Vasc Anesth 1991;5:13-7.
31. 31. Phillips ML, Schwarte BR, Etzioni A, et al. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 1995;96:2898-906.
32. 32. Kubes P, Suzuki M, Granger DN. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5.
33. 33. Gaboury JP, Kubes P. Endogenous antiadhesive molecules. In: Granger D, ed. Physiology and pathophysiology of leukocyte adhesion. New York: Oxford University Press, 1995: 241-60.
34. 34. Bevilacqua MP, Pober JS, Mendrick DL, et al. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA 1987,84:9238-42.
35. 35. Bevelaqua FA, Aranda C. Management of spontaneous pneumothorax with small lumen catheter manual aspiration. Chest 1982,81:693-4.
36. 36. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers. FASEB J 1995;9:899-909.
37. 37. Burns SA, DeGuzman BJ, Newburger JW, et al. P-selectin expression in myocardium of children undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;110: 924-33.
38. 38. Foreman KE, Vaporciyan AA, Bonish BK, et al. C5a-induced expression of P-selectin in endothelial cells. J Clin Invest 1994;94:1147-55.
39. 39. Bonser RS, Dave JR, John L, et al. Complement activation before, during and after cardiopulmonary bypass. Eur J Cardiothorac Surg 1990;4:291-6.
40. 40. Casey LC. Role of cytokines in the pathogenesis of cardiopulmonary-induced multisystem organ failure. Ann Thorac Surg 1993;56:S92-6.
41. 41. Chenoweth DE, Cooper SW, Hugli TE, et al. Complement activation during cardiopulmonary bapass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981;304:497-503.
42. 42. Finn A, Naik S, Klein N, et al. Interleukin-8 release and neutrophil degranulation after pediatric cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;105:234-41.
43. 43. Hennein HA, Ebba H, Rodriguez JL, et al. Relationship of the proinflammatory cytokines to myocardial ischemia and dysfunction after uncomplicated coronary revascularization. J Thorac Cardiovasc Surg 1994;108:626-35.
44. 44. Kilbridge PM, Mayer JE, Newburger JW, et al. Induction of intercellular adhesion molecule-1 and E-selectin mRNA in heart and skeletal muscle of pediatric patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1994;107: 1183-92.
45. 45. Verrier ED. The microvascular cell and ischemia-reperfusion injury. J Cardiovasc Pharmacol 1996;27:S26-30.
46. 46. Butler J, Chong GL, Baigrie RJ, et al. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992;53:833-8.
47. 47. Johnson MJ, Pohlman TH, Verrier ED. Neutrophil antiadhesion therapy for myocardial ischemia: clinical potential. Clin Immunother 1995;3:8-14.
48. 48. Mallory GK. The speed of healing of myocardial infarction. A study of the pathologic anatomy in seventy-two cases. Am Heart J 1939;18:647-71.
49. 49. Simpson PJ, Todd RF III, Fantone JC, et al. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti-Mo1, anti-CD11b) that inhibits leukocyte adhesion. J Clin Invest 1988;81:624-9.
50. 50. Engler RL, Dahlgren MD, Morris DD, et al. Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. Am J Physiol 1986;251:H314-22.
51. 51. Hearse DJ. Prospects for antioxidant therapy in cardiovascular medicine. Am J Med 1991;91:118S-21S.
52. 52. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxiamediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest 1992; 90:2333-9.
53. 53. Verrier ED, Shen I. Potential role of neutrophil antiadhesion therapy in myocardial stunning, myocardial infarction, and organ dysfunction after cardiopulmonary bypass. J Cardiac Surg 1993;8:309-12.
54. 54. Buerke M, Weyrich AS, Zheng Z, et al. Sialyl Lewisx-containing oligosaccharide attenuates myocardial reperfusion injury in cats. J Clin Invest 1994;93:1140-8.
55. 55. Byrne JG, Murphy MP, Smith WJ, et al. Prevention of CD18-mediated reperfusion injury enhances the efficacy of UW solution for 15-hr heart preservation. J Surg Res 1993;54: 625-30.
56. 56. Shen I, Verrier ED. Expression of E-selectin on coronary endothelium after myocardial ischemia and reperfusion. J Cardiac Surg 1994;9:437-41.
57. 57. Winn RK, Liggitt D, Vedder NB, et al. Anti-P-selectin monoclonal antibody attenuates reperfusion injury to the rabbit ear. J Clin Invest 1993;92:2042-7.
58. 58. Baldwin JC. Heart graft preservation. In: Shumway SJ, Shumway NE, eds. Thoracic transplantation. Cambridge: Blackwell Science, 1995:67-70.
59. 59. Lower RR. Foreword. In: Shumway SJ, Shumway NE, eds. Thoracic transplantation. Cambridge: Blackwell Scientific, 1990:xi-xii.
60. 60. Bando K, Schueler S, Cameron DE, et al. Twelve-hour cardiopulmonary preservation using donor core cooling, leukocyte depletion, and liposomal superoxide dismutase. J Heart Lung Transplant 1991;10:304-9.
61. 61. Bando K, Pillai R, Cameron DE, et al. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99:873-7.
62. 62. Byrne JG, Smith WJ, Murphy MP, et al. Complete prevention of myocardial stunning, contracture, low-reflow, and edema after heart transplantation by blocking neutrophil adhesion molecules during reperfusion. J Thorac Cardiovasc Surg 1992;104:1589-96.
63. 63. Clowes AW, Reidy MA. Prevention of stenosis after vascular reconstruction: pharmacologic control of intimai hyperplasia - a review. J Vasc Surg 1991;13:885-91.
64. 64. Clowes AW. Prevention and management of recurrent disease after arterial reconstruction: new prospects of pharmacological control. Thromb Haemost 1991;66:2-66.
65. 65. Ross R, Glomset JA. Atherosclerosis and arterial smooth muscle cell. Science 1973;180:1332-9.
66. 66. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
67. 67. Lorenzi M, Cagliero E, Toledo S. Glucose toxicity for human endothelial cells in culture: delayed replication, disturbed cell cycle, and accelerated death. Diabetes 1985;34:621-7.
68. 68. Billiar TR. Nitric oxide: novel biology with clinical relavance. Ann Surg 1995;221:339-49.
69. 69. Schiffrin EL. The endothelium and control of blood vessel function in health and disease. Clin Invest Med 1994;17: 602-20.